ZyVersa Therapeutics Inc. (ZVSA)
undefined
undefined%
At close: undefined
1.02
-2.88%
After-hours Dec 13, 2024, 04:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - - - -
Cost of Revenue 10.40K 10.40K 10.40K 10.40K
Gross Profit -10.40K -10.40K -10.40K -10.40K
Operating Income -14.42M -13.01M -7.70M -11.83M
Interest Income - 427.54 821.37 516.45
Pretax Income -107.75M -14.05M -8.08M -12.68M
Net Income -98.30M -759.10M -8.91M -13.20M
Selling & General & Admin 11.20M 7.61M 5.58M 5.36M
Research & Development 3.21M 5.41M 2.12M 6.47M
Other Expenses - - - -
Operating Expenses 14.41M 13.01M 7.70M 11.83M
Interest Expense -457.00K 427.54K 821.37K 516.45K
Selling & Marketing Expenses -11.20B - - -
Cost & Expenses 14.42M 13.01M 7.70M 11.83M
Income Tax -9.46M 745.05M 821.37K 516.45K
Shares Outstanding (Basic) 97.50K 25.95K 46.55K 46.55K
Shares Outstanding (Diluted) 97.50K 25.95K 46.55K 46.55K
EPS (Basic) -1.09K -930.25 -173.66 -272.45
EPS (Diluted) -1.09K -930.25 -173.66 -272.45
EBITDA -107.74M -11.67M -7.25M -12.16M
Depreciation & Amortization 10.40K 10.40K 10.40K 10.40K